Do you want to read an article? Please log in or register.
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
Multiple Sclerosis
RECOMMENDED
Related content
Multiple Sclerosis
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Mult Scler.
Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S
doi: 10.1177/1352458518765666.
Multiple Sclerosis
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Brain
Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J
doi: 10.1093/brain/awy154.
Multiple Sclerosis
Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
Lancet Neurol.
Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I
doi: 10.1016/
RECOMMENDED
Multiple Sclerosis
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Kuhle J, Plavina T, Barro C, Disanto G, Sangurdekar D, Singh CM, de Moor C, Engle B, Kieseier BC, Fisher E, Kappos L, Rudick RA, Goyal J
doi: 10.1177/1352458519885613.
Multiple Sclerosis
Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Ann Neurol.
Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss MS Cohort Study (SMSC) Group
doi: 10.1002/ana.24954.
Amyotrophic Lateral SclerosisDementia
Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease
JAMA Neurol.
Gaiani A, Martinelli I, Bello L, Querin G, Puthenparampil M, Ruggero S, Toffanin E, Cagnin A, Briani C, Pegoraro E, Sorarù G
doi: 10.1001/jamaneurol.
Multiple Sclerosis
De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis
Mult Scler.
Disanto G, Ripellino P, Riccitelli GC, Sacco R, Scotti B, Fucili A, Pravatà E, Kuhle J, Gobbi C, Zecca C
doi: 10.1177/
Dementia
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
Lancet Neurol.
van der Ende EL, Meeter LH, Poos JM, Panman JL, Jiskoot LC, Dopper EGP, Papma JM, de Jong FJ, Verberk IMW, Teunissen C, Rizopoulos D, Heller C, Convery RS, Moore KM, Bocchetta M, Neason M, Cash DM, Borroni B, Galimberti D, Sanchez-Valle R, Laforce R Jr, Moreno F, Synofzik M, Graff C, Masellis M, Carmela Tartaglia M, Rowe JB, Vandenberghe R, Finger E, Tagliavini F, de Mendonça A, Santana I, Butler C, Ducharme S, Gerhard A, Danek A, Levin J, Otto M, Frisoni GB, Cappa S, Pijnenburg YAL, Rohrer JD, van Swieten JC, Genetic Frontotemporal dementia Initiative (GENFI).
doi: 10.1016/S1474-4422(19)30354-0.
COMMENTED
Aging and Cognitive Functions
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
JAMA Neurol.
Olsson B, Portelius E, Cullen NC, Sandelius Å, Zetterberg H, Andreasson U, Höglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K
doi: 10.1001/jamaneurol.